The American Association of Clinical Urologists (AACU) has issued a position statement encouraging the use of tissue-based molecular testing and/or germline testing for three groups of prostate cancer patients. 2018 March 6, “Clinical Urologists Group Supports Genomic Testing for Prostate Cancer”, in ClinicalOMICs: